OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Carfilzomib weekly 20/56 mg/m<sup>2</sup>, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
Published in:
American Journal of Hematology, 2019, v. 94, n. 1, p. E17, doi. 10.1002/ajh.25327
By:
- Richez, Valentine;
- Gruchet, Cecile;
- Guidez, Stephanie;
- Fouquet, Guillemette;
- Azais, Isabelle;
- Durand, Geraldine;
- Javaugue, Vincent;
- Brigaud, Antoine;
- Plasse, Florent;
- Diolez, Jéremie;
- Machet, Antoine;
- Moya, Niels;
- Gardeney, Helene;
- Franques, Paul;
- Bobin, Arthur;
- Levy, Anthony;
- Sabirou, Florence;
- Bonnin, Anthony;
- Dieval, Celine;
- Primault, Sylvain
Publication type:
Article